Shareholders Foundation, Inc.

NASDAQ: SPPI Investor Notice: Lawsuit Alleges Securities Laws Violations by Spectrum Pharmaceuticals, Inc.

A lawsuit was filed on behalf of investors in Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) shares over alleged securities laws violations.


San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investor, who purchased NASDAQ: SPPI shares, filed a lawsuit against Spectrum Pharmaceuticals, Inc over alleged Securities Laws violations.

Investors who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and for certain investors are short and strict deadlines running. Deadline: November 1, 2021. NASDAQ: SPPI investors should contact the Shareholders Foundation at or call +1(858) 779 - 1554.

Henderson, NV based Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products.

On August 6, 2021, Spectrum Pharmaceuticals, Inc. announced the Company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding the Company's Biologics License Application for ROLONTIS®. The CRL cited deficiencies related to manufacturing and indicated that a reinspection of the Company's manufacturing facility would be necessary.

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) declined from $4.54 per share in June 2021 to as low as $2.27 per share on August 6, 2021.

The plaintiff claims that between December 27, 2018 and August 5, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that the ROLONTIS manufacturing facility maintained deficient controls and/or procedures, that the foregoing deficiencies decreased the likelihood that the FDA would approve the ROLONTIS BLA in its current form, that Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and should contact the Shareholders Foundation.

Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.